Yokogawa Electric Establishes Consortium to Develop Manufacturing Automation Platform for Regenerative Medicine Products

Key facts

  • Yokogawa Electric Establishes Consortium to Develop Manufacturing Automation Platform for Regenerative Medicine Products
  • Yokogawa Electric announced the formation of a consortium to develop a manufacturing automation platform for regenerative medicine products. The company is a global enterprise leveraging measurement, control, and information technologies to support industrial development in energy, chemicals, materials, pharmaceuticals, and food sectors.
  • Source: PR Times
  • Date: April 13, 2026

Direct answer

Yokogawa Electric announced the formation of a consortium to develop a manufacturing automation platform for regenerative medicine products. The company is a global enterprise leveraging measurement, control, and information technologies to support industrial development in energy, chemicals, materials, pharmaceuticals, and food sectors.

Citation
Yokogawa Electric Establishes Consortium to Develop Manufacturing Automation Platform for Regenerative Medicine Products (April 13, 2026), PR Times
Source
PR Times
Date
April 13, 2026
Yokogawa Electric announced the formation of a consortium to develop a manufacturing automation platform for regenerative medicine products. The company is a global enterprise leveraging measurement, control, and information technologies to support industrial development in energy, chemicals, materials, pharmaceuticals, and food sectors.
partnershipNQ 33/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: April 13, 2026 at 11:10
  • 🔍 Collected: April 13, 2026 at 12:51 (1h 41m after Published)
  • 🤖 AI Analyzed: April 15, 2026 at 01:52 (37h 0m after Collected)
Founded in 1915, Yokogawa Electric boasts a global network spanning 60 countries with over 17,000 employees. As the YOKOGAWA Group, it contributes to solving societal issues by leveraging its expertise in measurement, control, and information technologies. In its core "control business," the company has pioneered distributed control systems and autonomous control AI for plant production equipment, supporting industrial development in sectors such as energy, chemicals, materials, pharmaceuticals, and food. This new consortium focuses on developing an automation platform for regenerative medicine products.

FAQ

What are the key facts in this article?

Yokogawa Electric announced the formation of a consortium to develop a manufacturing automation platform for regenerative medicine products. The company is a global enterprise leveraging measurement, control, and information technologies to support industrial development in energy, chemicals, materials, pharmaceuticals, and food sectors.

What is the direct answer?

Yokogawa Electric announced the formation of a consortium to develop a manufacturing automation platform for regenerative medicine products. The company is a global enterprise leveraging measurement, control, and information technologies to support industrial development in energy, chemicals, materials, pharmaceuticals, and food sectors.

What is the source and date?

PR Times: https://prtimes.jp/main/html/rd/p/000000032.000160352.html | April 13, 2026

Back to Newsroom (4)